{
  "estudios": {
    "LIBREXIA SCA - Milvexian": {
      "exclusion": {
      },
      "inclusion": {
        "edad": [">65"],
        "antecedentes": ["infarto agudo de miocardio"],
        "factores": ["diabetes mellitus tipo 2"],
        "laboratorio": ["Troponina = +"]
      }
    },
    "GZQO - Retatrutida (GLP-1R y GCGR)": {
      "inclusion": {
        "factores": ["obesidad", "enfermedad renal cronica"],
        "laboratorio": ["filtrado glomerular <45","RAC >30",
          "filtrado glomerular <60", "RAC >100",
          "filtrado glomerular <75", "RAC >300"]
      },
      "exclusion": {
        "edad":["<45"],
        "laboratorio": ["hemoglobina glicosilada >10"]
    }
  },
  "HERMES - Ziltivekimab": {
    "inclusion": {
      "antecedentes": ["insuficiencia cardiaca"],
      "laboratorio": ["proteina c reactiva >2", "pro bnp>300"]
    },
    "exclusion": {
 }
},
    "BAX-DUO (ARTIC): Baxdrostat/Dapa vs Dapaglifozina": {
      "inclusion": {
        "factores": ["hipertension arterial"],
        "medicacion": ["enalapril", "ramipril", "losartan", "valsartan", "telmisartan"],
        "laboratorio": [
          "filtrado glomerular >30",
          "filtrado glomerular <60",
          "RAC >50",
          "RAC <500",
          "filtrado glomerular >30",
          "filtrado glomerular <75",
          "RAC >500",
          "RAC <5000"
        ]
      },
      "exclusion": {
        "laboratorio": ["hemoglobina glicosilada >10.5"],
        "medicacion": ["hidroclorotiazida"]
      }
    },
    "BAX-DUO (PREVENT HF): Baxdrostat/Dapa vs Dapaglifozina": {
      "inclusion": {
        "factores": ["hipertension arterial", "diabetes mellitus tipo 2"],
        "medicacion": ["enalapril", "ramipril", "losartan", "valsartan", "telmisartan"],
        "laboratorio": [
          "filtrado glomerular >30",
          "RAC <5000"
        ]
      },
      "exclusion": {
        "laboratorio": ["hemoglobina glicosilada >10.5"],
        "medicacion": ["hidroclorotiazida"]
      }
    },
     "AROAPOC3-3004 - SHASTA: PlozasirÃ¡n": {
    "inclusion": {
      "factores": ["hipertrigliceridemia"],
      "laboratorio": [
        "trigliceridos >500",
        "colesterol LDL < 130"
      ]
     },
    "exclusion": {
      "edad": ["<18"]
     }
   },
     "J3L-MC-EZEF: Lepodisiran": {
  "inclusion": {
  "laboratorio": [
   "trigliceridos >175"
  ]
    },
    "exclusion": {
    "edad": ["<55"]
    }
  },
  "BalanceD-HF: Balcinrenona/Dapa vs Dapa": {
"inclusion": {
  "antecedentes": ["insuficiencia cardiaca"],
"laboratorio": [
"trigliceridos >175"]
 },
 "exclusion": {
 "edad": ["<55"]
 }
 }
  }
}